Related Experiment Video
Updated: Sep 17, 2025
13:24
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
Avatar: Personalized Precision Radio-Genomic Theranostic Oncology.
1Department of Nuclear Medicine, The University of Western Australia, Fiona Stanley Fremantle Hospitals Group, Fremantle, Australia.
Cancer Biotherapy & Radiopharmaceuticals
|June 27, 2025
Summary
Creating a virtual patient avatar using artificial intelligence can revolutionize cancer theranostics. This digital twin enables personalized N-of-1 treatment strategies and real-time optimization for improved patient outcomes.
Area of Science:
- Oncology
- Bioinformatics
- Artificial Intelligence
Background:
- Cancer treatment is increasingly personalized, but challenges remain in tailoring therapies to individual patients' unique molecular and genomic profiles.
- Current theranostic approaches often lack the ability to dynamically adapt to a patient's evolving cancer biology.
Discussion:
- A virtual avatar, or digital twin, can be created using a patient's comprehensive data, including radio-genomics, tumor pathology, and molecular biology.
- This digital twin simulates the patient's unique cancer, allowing for ex vivo testing of N-of-1 theranostic strategies in real time.
Key Insights:
- Virtual patient avatars enable the simulation of individual cancer characteristics and responses to treatment.
- This approach facilitates the design and testing of highly personalized, N-of-1 theranostic strategies.
- Real-time adaptation of treatment based on avatar predictions can optimize clinical outcomes.
Outlook:
- Virtual avatars hold significant potential for transforming precision oncology by enabling truly individualized cancer care.
- Continued data analysis and avatar refinement will allow for predictive modeling of tumor response and adaptive treatment strategies.
- This technology promises to enhance the efficacy and efficiency of cancer theranostics.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
667
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
667